Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod. Hoepner R, Havla J, Eienbröker C, Tackenberg B, Hellwig K, Meinl I, Hohlfeld R, Gold R, Kümpfel T, Kleiter I Mult Scler. 2014 May 19. PMID: 24842961. Abstract CommentRecommendBookmarkWatch